NCT00900575Recruiting
Cervical Cancer Detection Using Optical Spectroscopy
Source: ClinicalTrials.gov · Last updated 6 Mar 2026
Brief summary (registry, in English)
The objective of the work described in this protocol is to determine the optical signatures of cervical dysplasia using optical technologies.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 350 (estimated)
- First submitted
- 11 May 2009
- Start date
- May 2006
- Primary completion date
- 31 Jan 2028
- Lead sponsor
- Duke University
- Diseases
- Cervical cancer
- NCT number
- NCT00900575
What you commit to
- Study type: Interventional
- Planned participants: 350
- From May 2006 to the primary completion date, 31 Jan 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- patients will be excluded if she has had a recent episode of bleeding or preterm labor.
Age
- Women under the age of 18 (minors) will be excluded from this study.
Other
- Subjects who are not competent to give consent will excluded
Who the study is looking for
- undergoing colposcopy for the diagnosis of cervical cancer
- LEEP for the treatment of cervical cancer in early stages.
- Follow-up Pap smear in surveillance
Age in the registry: 18 years to - · Sex: Female · Accepts healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Duke University Medical Center Coordinator of this site? Confirm its status | Durham | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.